A Study of Obinutuzumab (RO5072759) in Combination With CHOP Chemotherapy Versus MabThera/Rituxan (Rituximab) With CHOP in Patients With CD20-Positive

HOME | CONTACT | PATIENT LOGIN | CLINIC LOGIN | FAQ

TRIAL ALERTS

Site Listing

Please choose the site that is most convenient for you

Study Name: A Study of Obinutuzumab (RO5072759) in Combination With CHOP Chemotherapy Versus MabThera/Rituxan (Rituximab) With CHOP in Patients With CD20-Positive
5 locations found

Study Name Unavailable
Location: Galesburg, Illinois 61401
Study Name Unavailable
Location: Winston-salem, North Carolina 27103
Study Name Unavailable
Location: Columbia, South Carolina 29210
Study Name Unavailable
Location: Nashville, Tennessee 37203
Study Name Unavailable
Location: Richmond, Virginia 23230

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted worldwide.

ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.

TRIAL ALERTS

HEALTH NEWS

RSS FEEDS

ABOUT TRIALS

LINK TO US

Site Listing